- Training Institute for Specialists by the Oto-Rhino-Laryngological (ORL) Society of Japan
- Training Institute for Specialists by the Japan Broncho-Esophagological Society
- Associate Training Institute for specialists of Head and Neck Cancer by the Japan Society for Head and Neck Surgery
- Training Institute for Specialists by the Japan Association of Endocrine Surgeons and the Japanese Society of Thyroid Surgery
- Training Institute for General Clinical Oncologists by Japanese Board of Cancer Therapy
Friday, March 24, 2017
Introduction
Thursday, March 23, 2017
Allergic Rhinitis
Argon Plasma Coagulation (APC) for allergic rhinitis
Endoscopic Sinus Surgery (ESS)
Chronic sinusitis with nasal polyp
Recurrent acute sinusitis
Fungal sinusitis
Eosinophilic sinusitis
Inverted papilloma
Allergic rhinitis with severe nasal obstruction
Nasal septal deviation
Postnasal bleeding
We conduct more than 80 endoscopic sinus surgery (ESS) under general anesthesia each year.
Upper respiratory tract infection
We administer intravenous injection of penicillin (Ampicillin/ Sulbactam) to the patients with upper respiratory tract infectious disease.
We incise and drain to the patients with the abscess.
We conduct Quinsy tonsillectomy for the treatment of inferior type of peritonsillar abscess.
Tuesday, March 21, 2017
Swallowing disorder
Obstructive Sleep Apnea Syndrome (OSAS)
Chronic otitis media and cholesteatoma
Saturday, March 18, 2017
Ear tube insertion for recurrent acute otitis media and otitis media with effusion
Facial nerve paralysis
Friday, March 17, 2017
Sudden sensorineural hearing loss
Thursday, March 16, 2017
Head and neck cancer
We
provide patient-centered care from a multidisciplinary team that focuses on
treating cancers of the head and neck. Head
and neck cancers and benign tumors are originated in:
Ear
Nose and sinus cavity
Larynx (Voice box)
Nasopharynx
Oropharynx (tonsil, base of tongue)
Hypopharynx
Oral cavity (tongue)
Skull base
Salivary glands
Thyroid gland
Parathyroid gland
Head and neck cancer team at Hokuto Hospital includes not just head and neck
surgeons, but it also includes radiologists, oral surgeons, dentists, and
plastic surgeons. Others in many subspecialties—neurosurgeons,
ophthalmologists, doctors practicing palliative medicine, pathologists,
anesthesiologists, pharmacists, speech therapists and experienced head and neck
cancer nurses—work closely with our core team to deliver comprehensive and
personalized care to our patients with head and neck cancer.
We
can provide microvascular reconstruction using a free flap for surgical defects
after removal of head and neck cancers. We can also take a proactive stance for
chemotherapy with anticancer drugs including molecular target drugs and
image-guided, intensity-modulated radiation therapy (IG-IMRT). Patients
diagnosed with head and neck cancer face unique challenges that can greatly
affect quality of life. Unlike other malignancies, head and neck cancer has the
potential to significantly affect a patient’s appearance, speech, swallowing,
and other senses. We proactively work to optimize each patient’s quality of
life and provide the best treatments for preservation of speech, taste and
swallowing functions, as well as maintaining overall physical appearance.
|
TomoTherapy (Intensity modulated radiotherapy)
IA chemoradiation
Thyroid surgery
Video Assisted Neck Surgery (VANS)
Monday, March 13, 2017
Members
Nobuyuki Bandoh
Vice-Director,
Hokuto Hospital
Chairman,
Head and Neck Cancer Center,
Hokuto Hospital
Chief,
Department
of Otolaryngology-Head
and
Neck Surgery,
Hokuto Hospital
Clinical Professor,
Asahikawa Medical University
Part-time instructor, Asahikawa
Medical University
Education:
1992 M.D. awarded
2002 Ph.D. awarded
Previous appointments:
1998-2008 Instructor,
Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical
University
2001-2003 Research
Affiliate,
Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA
2005 Completion of training course
of temporal bone dissection, House Ear Institute, Los Angeles, USA
2008-2009 Assistant
Professor,
Asahikawa Medical University
2009- Chief,
Otolaryngology-Head
and Neck Surgery,
Hokuto Hospital
Board Certification:
Board Certified Otorhinolaryngologist by
the ORL Society of Japan
Board Certified Bronchoesophagologist by
the Japan Broncho-Esophagological
Society
Certification as a Specialist of
Head and Neck Cancer by the Japan Society for Head and Neck Surgery
Certification as a Specialist by
Japan Association of Endocrine Surgeons and the Japanese Society of Thyroid
Surgery
General Clinical Oncologist by
Japanese Board of Cancer Therapy
American Association for Cancer
Research (AACR) active member
Takashi Goto
Chief, Department of Otolaryngology-Head and Neck Surgery, Hokuto Hospital Assistant manager, Head and Neck Cancer Center, Hokuto Hospital Clinical Associate Professor, Asahikawa Medical University Part-time instructor, Asahikawa Medical University Member,Sun International Clinic
1997 M.D.
awarded
2010 Ph.D.
awarded
2007
Staff, Department of Otolaryngology-Head
and Neck Surgery, Hokuto Hospital
2005
Otology surgery training at Michigan University in
USA
2008
Otolaryngology surgery training at British
Columbia University in
Canada
2011
Nose surgery training at Marburg University in
Germany
Board
Certification:
Board
Certified Otorhinolaryngologist
by the ORL Society of Japan
General
Clinical Oncologist by Japanese Board of Cancer Therapy
Akihiro Uemura
Member, Department of Otolaryngology-Head and Neck Surgery
2006 M.D. awarded 2013 Board Certified Otorhinolaryngologist by the ORL Society of Japan Shiori Suzuki
Member, Department of Otolaryngology-Head and Neck Surgery
2016 M.D. awarded |
Sunday, March 12, 2017
References
1) Suzuki S, Tsuda H, Bandoh N, Goto T,
Uemura A, Aoyama T, Nishio A, Makino S, Yamaguchi T, Aimono E, Nishihara H,
Harabuchi Y: Diffuse-type tenosynovial giant cell tumor arising in the
temporomandibular joint extending to the external auditory canal: A case report
and literature review. Ear Nose Throat J 2021, http://doi:
10.1177/01455613211002954
2) Bandoh N, Katada A, Kono M: Endoscopic Endonasal and
Transmaxillary approach for resection of juvenile nasopharyngeal angiofibroma
with preoperative embolization in a child. J Craniofac Surg 2021, http://doi: 10.1097/SCS.0000000000007495
3) Suzuki S, Bandoh N, Goto T, Uemura A,
Sasaki M, Harabuchi Y. Severe laryngeal edema caused by Pseudoterranova
species: A case report. Medicine (Baltimore) 2021, http://doi:
10.1097/MD.0000000000024456
4) Sato R, Bandoh N, Goto T, Ichikawa H,
Uemura A, Suzuki S, Yamaguchi T, Aimono E, Nishihara H, Katada A, Harabuchi Y:
Kimura disease presenting with buccal mass: A Case Report and Literature
Review. Head Neck Pathol 2020, http://doi:
10.1007/s12105-020-01206-3
5) Sato R, Bandoh N, Goto T, Uemura A,
Inoue N, Otomo Y, Nakano H, Yamaguchi T, Kato Y, Nishihara H, Takei H,
Harabuchi Y: Resection of a desmoid-type fibromatosis with a CTNNB1 p.S45P
mutation using a cervico-thoracic approach: A case report and literature
review. Auris Nasus Larynx 2020, http://doi: 10.1016/j.anl.2020.05.004.
6) Bandoh N, Ichikawa H, Asahi A, Kono M, Harabuchi S, Sato R,
Uemura A, Goto T, Yamaguchi T, Kato Y, Furukawa H, Takei H, Harabuchi Y: Lung
adenocarcinoma with cheek dysesthesia as an initial symptom: A case report and
literature review. Case Rep Oncol 12(2): 650-6, 2019
7)
Bandoh
N, Akahane T,
Goto T, Kono M, Ichikawa H, Sawada T, Yamaguchi T, Nakano H, Kawase Y, Kato Y,
Kamada H,
Harabuchi Y, Nishihara H:Targeted next‑generation sequencing
of cancer‑related genes in thyroid carcinoma: A single institution's experience.
Oncol Lett 16(6): 7278-86, 2018
8)
Kono M, Bandoh N, Goto
T, Harabuchi Y: A
clinical study of patients with acute epiglottitis. Int J Pract Otolaryngol
1: e1-5, 2018,
https://doi.org/10.1055/s-0038-1660522.
9)
Kono M, Bandoh N,
Matsuoka R, Goto T, Akahane T, Kato Y, Nakano H, Yamaguchi T, Harabuchi Y,
Nishihara H:Glomangiopericytoma
of the Nasal Cavity with CTNNB1 p.S37C Mutation: A Case Report and Literature
Review. Head Neck Pathol 13(3):298-303, 2019
10)
Harabuchi S, Bandoh
N, Yasukawa R, Kono M, Goto T, Harabuchi Y, Ikeda H, Kamada H,
Nishihara H: ANCA-negative granulomatosis with polyangiitis presenting with
hypertrophic cranial pachymeningitis, abducens nerve palsy, and stenosis of the
internal carotid artery. Case Rep Otolaryngol, http://doi: 10.1155/2017/9687383
11)
Bandoh N, Goto T, Akahane T,
Ohnuki N, Yamaguchi T, Kamada H, Harabuchi Y, Tanaka S, Nishihara H: Diagnostic
value of liquid-based cytology with fine needle aspiration specimens for
cervical lymphadenopathy. Diagn
Cytopathol, 44: 169-176, 2016
12)
Takahashi Y, Bandoh
N, Miyamoto A, Kamada H: Single-fraction helical tomotherapy for
ameloblastic carcinoma. J Oral
Maxillofac Surg, 74: 302-306, 2015
13)
Tempaku A, Takahashi Y, Ikeda H, Yamauchi S, Goto T, Bandoh N, et al.: Usefulness of
C-methionine positron emission tomography for detecting intracranial
ameloblastic carcinoma: A case report. Oncol
Lett, 8: 1509-1512, 2014
14)
Bandoh N, Yoshizaki T, Ishida Y,
Goto T, Takahara M, Hayashi T, Harabuchi Y, Kumai M,Yamanaka N: Evalution of
the clinical efficacy of antibiotics using a scoring system for acute
pharyngo-tonsillitis. Adv. Otolaryngol,72:
212, 2011.
15)
Bandoh N, Ogino T, Katayama A,
Takahara M, Katada A, Hayashi T, Harabuchi Y: HLA class I antigen and
transporter associated with antigen processing downregulation in metastatic
lesions of head and neck squamous cell carcinoma as a marker of poor prognosis. Oncol Rep, 23: 933-939, 2010.
16)
Goto T, Bandoh N,
Nagato T, Takahara M, Harabuchi Y, Tokusashi Y, Miyokawa N: Primary small cell
carcinoma of lacrimal sac: case report and literature review. J Laryngol Otol, 124: 1223-1226, 2010.
17)
Ota R, Katada A, Bandoh
N, Takahara M, Kishibe K, Hayashi T, Harabuchi Y: A case of invasive
paranasal aspergillosis that developed from a non-invasive form during 5-year
follow-up. Auris Nasus Larynx, 37(2):
250-4, 2010.
18)
Yoshizaki T, Bandoh
N, Ueda S, Nozawa H, Goto T, Kishibe K, Takahara M, Harabuchi Y:
Up-regulation of CC chemokine receptor 6 on tonsillar T cells and its induction
by in vitro stimulation with alpha-streptococci in patients with pustulosis
palmaris et plantaris. Clin Exp Immunol,
157: 71-82, 2009.
19)
Goto T, Bandoh N,
Yoshizaki T, Nozawa H, Takahara M, Ueda S, Hayashi T, Harabuchi Y: Increase in
B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar
mononuclear cells stimulated with deoxycytidyl-deoxyguanosine
oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy. Clin Immunol, 126: 260-269, 2008.
20)
Nozawa H, Takahara M, Yoshizaki T, Goto T, Bandoh N, Harabuchi Y: Selective
expansion of T cell receptor (TCR) V beta 6 in tonsillar and peripheral blood T
cells and its induction by in vitro stimulation with Haemophilus parainfluenzae
in patients with IgA nephropathy. Clin
Exp Immunol, 151: 25-33, 2008.
21)
Katayama A, Ogino T, Bandoh
N, Takahara M, Kishibe K, Nonaka S, Harabuchi Y: Overexpression of
small ubiquitin-related modifier-1 and sumoylated Mdm2 in oral squamous cell
carcinoma: possible involvement in tumor proliferation and prognosis. Int J Oncol, 31: 517-524, 2007.
22)
Nagamine M, Kishibe K, Takahara M, Nagato T, Ishii H, Bandoh N, Ogino T, Harabuchi Y:
Selected amino acid change encoding Epstein-Barr virus-specific T cell epitope
of the LMP2A gene in Japanese nasal NK/T cell lymphoma patients. Intervirology, 50: 319-322, 2007.
23)
Xu JX, Hoshida Y, Yang WI, Inohara H, Kubo T, Kim GE, Yoon
JH, Kojya S, Bandoh N,
Harabuchi Y, Tsutsumi K, Koizuka I, Jia XS, Kirihata M, Tsukuma H, Aozasa K:
Life-style and environmental factors in the development of nasal NK/T-cell
lymphoma: a case-control study in East Asia. Int J Cancer, 120: 406-410, 2007.
24)
Nagamine M, Takahara M, Kishibe K, Nagato T, Ishii H, Bandoh N, Ogino T, Harabuchi Y:
Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell
lymphoma. Virus Genes, 34: 47-54,
2007.
25)
Shigyo H, Nonaka S, Katada A, Bandoh N, Ogino T, Katayama A, Takahara M, Hayashi T,
Harabuchi Y: Inducible nitric oxide synthase expression in various laryngeal
lesions in relation to carcinogenesis, angiogenesis, and patients' prognosis. Acta Otolaryngol, 127: 970-979, 2007.
26)
Chang CC, Ogino T, Mullins DW, Oliver JL, Yamshchikov GV, Bandoh N, Slingluff CL, Jr.,
Ferrone S: Defective human leukocyte antigen class I-associated antigen
presentation caused by a novel beta2-microglobulin loss-of-function in melanoma
cells. J Biol Chem, 281:
18763-18773, 2006.
27)
Bandoh N, Hayashi T, Takahara M,
Kishibe K, Ogino T, Katayama A, Imada M, Nonaka S, Harabuchi Y: Loss of p21
expression is associated with p53 mutations and increased cell proliferation
and p27 expression is associated with apoptosis in maxillary sinus squamous
cell carcinoma. Acta Otolaryngol,
125: 779-785, 2005.
28)
Bandoh N, Ogino T, Cho HS, Hur SY,
Shen J, Wang X, Kato S, Miyokawa N, Harabuchi Y, Ferrone S: Development and
characterization of human constitutive proteasome and immunoproteasome
subunit-specific monoclonal antibodies. Tissue
Antigens, 66: 185-194, 2005.
29)
Katayama A, Ogino T, Bandoh
N, Nonaka S, Harabuchi Y: Expression of CXCR4 and its down-regulation
by IFN-gamma in head and neck squamous cell carcinoma. Clin Cancer Res, 11: 2937-2946, 2005.
30)
Wang X, Campoli M, Cho HS, Ogino T, Bandoh N, Shen J, Hur SY, Kageshita T, Ferrone S: A method
to generate antigen-specific mAb capable of staining formalin-fixed,
paraffin-embedded tissue sections. J
Immunol Methods, 299: 139-151, 2005.
31)
Katayama A, Bandoh
N, Kishibe K, Takahara M, Ogino T, Nonaka S, Harabuchi Y: Expressions
of matrix metalloproteinases in early-stage oral squamous cell carcinoma as
predictive indicators for tumor metastases and prognosis. Clin Cancer Res, 10: 634-640, 2004.
32)
Bandoh N, Hayashi T, Takahara M,
Kishibe K, Ogino T, Katayama A, Imada M, Nonaka S, Harabuchi Y: VEGF and bFGF
expression and microvessel density of maxillary sinus squamous cell carcinoma
in relation to p53 status, spontaneous apoptosis and prognosis. Cancer Lett, 208: 215-225, 2004.
33)
Takahara M, Kishibe K,
Bandoh N, Nonaka S, Harabuchi Y: P53, N- and K-Ras, and beta-catenin
gene mutations and prognostic factors in nasal NK/T-cell lymphoma from
Hokkaido, Japan. Hum Pathol, 35:
86-95, 2004.
34)
Bandoh N, Ogino T, Hayashi T, Nonaka
S, Harabuchi Y, Miyokawa N, Ferrone S: HLA class I antigen defects in maxillary
sinus suquamous cell carcinoma: potential prognostic significance. International Congress Series (IFOS)
1240: 487-488, 2003.
35)
Bandoh N, Ogino T, Hayashi T,
Kishibe K, Takahara M, Imada M, Nonaka S, Harabuchi Y: Value of biological
factors for prognosis in maxillary sinus squamous cell carcinoma: p53 gene mutations and apoptosis. International Congress Series (IFOS) 1240: 489-490, 2003.
36) Bandoh N, Chang CC, Cho HS, Wang XH, Ogino T, Harabuchi Y, Whiteside
TL, Ferrone S: HLA class I antigen downregulation in human head and neck
squamous cell carcinoma cell lines: Role of antigen processing machinery
defects. Proc. Amer. Assoc. Cancer Res.
(2nd ed.), 770: 3868, 2003.
37)
Ogino T, Bandoh N,
Hayashi T, Miyokawa N, Harabuchi Y, Ferrone S: Association of tapasin and HLA
class I antigen down-regulation in primary maxillary sinus squamous cell
carcinoma lesions with reduced survival of patients. Clin Cancer Res, 9: 4043-4051, 2003.
38)
Bandoh N, Hayashi T, Kishibe K,
Takahara M, Imada M, Nonaka S, Harabuchi Y: Prognostic value of p53 mutations,
bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma. Cancer, 94: 1968-1980, 2002.
39)
Hayashi T, Nonaka S, Bandoh
N, Kobayashi Y, Imada M, Harabuchi Y: Treatment outcome of maxillary
sinus squamous cell carcinoma. Cancer,
92: 1495-1503, 2001.
-
The Department of Otolaryngology–Head and Neck Surgery at Hokuto Hospital was established in 2007. As the core hospital in eastern Hokkai...
-
VANS is a new surgical procedure for thyroid surgery, which was developed by Professor Kazuo Shimizu in 1998. Conventional thyroid surger...
-
The insertion of an ear tube reduces the occurrence of middle ear infections and allows the drainage of excess fluids. The most common i...